Literature DB >> 18835857

Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number.

A Hogart1, K N Leung, N J Wang, D J Wu, J Driscoll, R O Vallero, N C Schanen, J M LaSalle.   

Abstract

BACKGROUND: Chromosome 15q11-13 contains a cluster of imprinted genes essential for normal mammalian neurodevelopment. Deficiencies in paternal or maternal 15q11-13 alleles result in Prader-Willi or Angelman syndromes, respectively, and maternal duplications lead to a distinct condition that often includes autism. Overexpression of maternally expressed imprinted genes is predicted to cause 15q11-13-associated autism, but a link between gene dosage and expression has not been experimentally determined in brain.
METHODS: Postmortem brain tissue was obtained from a male with 15q11-13 hexasomy and a female with 15q11-13 tetrasomy. Quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) was used to measure 10 15q11-13 transcripts in maternal 15q11-13 duplication, Prader-Willi syndrome, and control brain samples. Southern blot, bisulfite sequencing and fluorescence in situ hybridisation were used to investigate epigenetic mechanisms of gene regulation.
RESULTS: Gene expression and DNA methylation correlated with parental gene dosage in the male 15q11-13 duplication sample with severe cognitive impairment and seizures. Strikingly, the female with autism and milder Prader-Willi-like characteristics demonstrated unexpected deficiencies in the paternally expressed transcripts SNRPN, NDN, HBII85, and HBII52 and unchanged levels of maternally expressed UBE3A compared to controls. Paternal expression abnormalities in the female duplication sample were consistent with elevated DNA methylation of the 15q11-13 imprinting control region (ICR). Expression of non-imprinted 15q11-13 GABA receptor subunit genes was significantly reduced specifically in the female 15q11-13 duplication brain without detectable GABRB3 methylation differences.
CONCLUSION: Our findings suggest that genetic copy number changes combined with additional genetic or environmental influences on epigenetic mechanisms impact outcome and clinical heterogeneity of 15q11-13 duplication syndromes.

Entities:  

Mesh:

Year:  2008        PMID: 18835857      PMCID: PMC2634820          DOI: 10.1136/jmg.2008.061580

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  34 in total

1.  The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A.

Authors:  M Runte; A Hüttenhofer; S Gross; M Kiefmann; B Horsthemke; K Buiting
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

2.  The human aminophospholipid-transporting ATPase gene ATP10C maps adjacent to UBE3A and exhibits similar imprinted expression.

Authors:  L B Herzing; S J Kim; E H Cook ; D H Ledbetter
Journal:  Am J Hum Genet       Date:  2001-05-11       Impact factor: 11.025

3.  Allele-specific expression analysis by RNA-FISH demonstrates preferential maternal expression of UBE3A and imprint maintenance within 15q11- q13 duplications.

Authors:  Laura B K Herzing; Edwin H Cook; David H Ledbetter
Journal:  Hum Mol Genet       Date:  2002-07-15       Impact factor: 6.150

4.  A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome.

Authors:  M Meguro; A Kashiwagi; K Mitsuya; M Nakao; I Kondo; S Saitoh; M Oshimura
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

Review 5.  The phenotypic manifestations of interstitial duplications of proximal 15q with special reference to the autistic spectrum disorders.

Authors:  P F Bolton; N R Dennis; C E Browne; N S Thomas; M W Veltman; R J Thompson; P Jacobs
Journal:  Am J Med Genet       Date:  2001-12-08

6.  Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization.

Authors:  J Cavaillé; K Buiting; M Kiefmann; M Lalande; C I Brannan; B Horsthemke; J P Bachellerie; J Brosius; A Hüttenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb.

Authors:  Akiko Kashiwagi; Makiko Meguro; Hidetoshi Hoshiya; Masayuki Haruta; Fumitoshi Ishino; Toshiyuki Shibahara; Mitsuo Oshimura
Journal:  J Hum Genet       Date:  2003-03-12       Impact factor: 3.172

8.  Atp10a, the mouse ortholog of the human imprinted ATP10A gene, escapes genomic imprinting.

Authors:  Tomohiko Kayashima; Kentaro Yamasaki; Keiichiro Joh; Takahiro Yamada; Tohru Ohta; Koh-ichiro Yoshiura; Naomichi Matsumoto; Yoshibumi Nakane; Tsunehiro Mukai; Norio Niikawa; Tatsuya Kishino
Journal:  Genomics       Date:  2003-06       Impact factor: 5.736

Review 9.  Angelman syndrome: a review of the clinical and genetic aspects.

Authors:  J Clayton-Smith; L Laan
Journal:  J Med Genet       Date:  2003-02       Impact factor: 6.318

10.  Multiple forms of atypical rearrangements generating supernumerary derivative chromosome 15.

Authors:  Nicholas J Wang; Alexander S Parokonny; Karen N Thatcher; Jennette Driscoll; Barbara M Malone; Naghmeh Dorrani; Marian Sigman; Janine M LaSalle; N Carolyn Schanen
Journal:  BMC Genet       Date:  2008-01-04       Impact factor: 2.797

View more
  52 in total

1.  Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF Veterans.

Authors:  Giulio M Pasinetti; Lap Ho; Christopher Dooley; Bhavna Abbi; Gudrun Lange
Journal:  Am J Neurodegener Dis       Date:  2012-04-24

Review 2.  Epigenetics, autism spectrum, and neurodevelopmental disorders.

Authors:  Sampathkumar Rangasamy; Santosh R D'Mello; Vinodh Narayanan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 3.  Evolving role of MeCP2 in Rett syndrome and autism.

Authors:  Janine M LaSalle; Dag H Yasui
Journal:  Epigenomics       Date:  2009-10       Impact factor: 4.778

4.  Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome.

Authors:  Makiko Meguro-Horike; Dag H Yasui; Weston Powell; Diane I Schroeder; Mitsuo Oshimura; Janine M Lasalle; Shin-ichi Horike
Journal:  Hum Mol Genet       Date:  2011-07-01       Impact factor: 6.150

Review 5.  DNA Methylation and Susceptibility to Autism Spectrum Disorder.

Authors:  Martine W Tremblay; Yong-Hui Jiang
Journal:  Annu Rev Med       Date:  2019-01-27       Impact factor: 13.739

6.  Levels of select PCB and PBDE congeners in human postmortem brain reveal possible environmental involvement in 15q11-q13 duplication autism spectrum disorder.

Authors:  Michelle M Mitchell; Rima Woods; Lai-Har Chi; Rebecca J Schmidt; Isaac N Pessah; Paul J Kostyniak; Janine M LaSalle
Journal:  Environ Mol Mutagen       Date:  2012-08-29       Impact factor: 3.216

7.  Cumulative Impact of Polychlorinated Biphenyl and Large Chromosomal Duplications on DNA Methylation, Chromatin, and Expression of Autism Candidate Genes.

Authors:  Keith W Dunaway; M Saharul Islam; Rochelle L Coulson; S Jesse Lopez; Annie Vogel Ciernia; Roy G Chu; Dag H Yasui; Isaac N Pessah; Paul Lott; Charles Mordaunt; Makiko Meguro-Horike; Shin-Ichi Horike; Ian Korf; Janine M LaSalle
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

Review 8.  A genomic point-of-view on environmental factors influencing the human brain methylome.

Authors:  Janine M LaSalle
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

9.  GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism.

Authors:  J L Silverman; M C Pride; J E Hayes; K R Puhger; H M Butler-Struben; S Baker; J N Crawley
Journal:  Neuropsychopharmacology       Date:  2015-03-10       Impact factor: 7.853

Review 10.  Rhythms of life: circadian disruption and brain disorders across the lifespan.

Authors:  Ryan W Logan; Colleen A McClung
Journal:  Nat Rev Neurosci       Date:  2019-01       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.